Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas

por Cleven, Arjen H. G., van Engeland, Manon, Wouters, Bradly G., de Bruïne, Adriaan P.
Publicado 2007

Molecular findings in maxillofacial bone tumours and its diagnostic value

por Cleven, Arjen H.G., Schreuder, Willem H., Groen, Eline, Kroon, Herman M., Baumhoer, Daniel
Publicado 2019

Treatment of Progressive Cherubism during the Second Dental Transitional Phase with Calcitonin

por Meijer, Ethan, van den Berg, Henk, Cleven, Arjen H. G., Edelenbos, Esther, Schreuder, Willem H.
Publicado 2023

Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

por Lou, Sha, Balluff, Benjamin, Cleven, Arjen H. G., Bovée, Judith V. M. G., McDonnell, Liam A.
Publicado 2016

Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis

por Lam, Suk Wai, van Langevelde, Kirsten, Suurmeijer, Albert J H, Cleven, Arjen H G, Bovée, Judith V M G
Publicado 2019

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

por Sundara, Yayan T., Kostine, Marie, Cleven, Arjen H. G., Bovée, Judith V. M. G., Schilham, Marco W., Cleton-Jansen, Anne-Marie
Publicado 2016

Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma

por Lam, Suk Wai, Cleven, Arjen H. G., Kroon, Herman M., Briaire-de Bruijn, Inge H., Szuhai, Karoly, Bovée, Judith V. M. G.
Publicado 2019

Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours

por Cleven, Arjen H. G., Schreuder, Willem H., Groen, Eline, de Lange, Jan, Briaire-de Bruijn, Inge H., Bovée, Judith V. M. G.
Publicado 2022

Corresponding anaplastic lymphoma kinase–tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus

por Melchers, Rutger C., Willemze, Rein, van Doorn, Remco, Jansen, Patty M., Cleven, Arjen H.G., Solleveld, Nienke, Vermeer, Maarten H., Quint, Koen D.
Publicado 2019

Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma

por Slot-Steenks, Mathilde M. Bruins, Hamdy, Neveen A.T., van de Sande, Michiel A.J., Vriens, Dennis, Cleven, Arjen H.G., Appelman-Dijkstra, Natasha M.
Publicado 2016

B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement

por Kemps, Paul G., Cleven, Arjen H. G., van Wezel, Tom, van Eijk, Ronald, Bot, Freek J., Veelken, Hendrik, van Balen, Peter, Kerkhoffs, Jean‐Louis H.
Publicado 2020

High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas

por Lou, Sha, Cleven, Arjen H. G., Balluff, Benjamin, de Graaff, Marieke, Kostine, Marie, Briaire-de Bruijn, Inge, McDonnell, Liam A., Bovée, Judith V. M. G.
Publicado 2016

Current Pathologic Scoring Systems for Metal-on-metal THA Revisions are not Reproducible

por Smeekes, Christiaan, Cleven, Arjen H. G., van der Wal, Bart C. H., Dubois, Stefan V., Rouse, Remigio W., Ongkiehong, Bastiaan F., Wolterbeek, Ron, Nelissen, Rob G. H. H.
Publicado 2017

NTRK fusions are extremely rare in bone tumours

por Lam, Suk Wai, Briaire‐de Bruijn, Inge H, van Wezel, Tom, Cleven, Arjen H G, Hogendoorn, Pancras C W, Cleton‐Jansen, Anne‐Marie, Bovée, Judith V M G
Publicado 2021

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

por Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2013

IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

por Cleven, Arjen H. G., Suijker, Johnny, Agrogiannis, Georgios, Briaire-de Bruijn, Inge H., Frizzell, Norma, Hoekstra, Attje S., Wijers-Koster, Pauline M., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Publicado 2017

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone

por Peterse, Elisabeth F. P., Cleven, Arjen H. G., De Jong, Yvonne, Briaire-de Bruijn, Inge, Fletcher, Jonathan A., Danen, Erik H. J., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Publicado 2016

Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method

por Rijs, Zeger, Belt, Esther, Kalisvaart, Gijsbert M., Sier, Cornelis F. M., Kuppen, Peter J. K., Cleven, Arjen H. G., Vahrmeijer, Alexander L., van de Sande, Michiel A. J., van Driel, Pieter B. A. A.
Publicado 2023

Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation

por Peterse, Elisabeth F. P., Niessen, Bertine, Addie, Ruben D., de Jong, Yvonne, Cleven, Arjen H. G., Kruisselbrink, Alwine B., van den Akker, Brendy E. W. M., Molenaar, Remco J., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Publicado 2018

Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies

por Kostine, Marie, Briaire-de Bruijn, Inge H., Cleven, Arjen H. G., Vervat, Carly, Corver, Willem E., Schilham, Marco W., Van Beelen, Els, van Boven, Hester, Haas, Rick L., Italiano, Antoine, Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Publicado 2017